Anesteziologie a intenzivní medicína, 2024 (vol. 35), issue 3

Editorial

CSARIM awards: what is their meaning in the context of the field

prof. MUDr. Vladimír Černý, Ph.D., FCCM, FESAIC, prof. MUDr. Jan Beneš, Ph.D. 

Anest. intenziv. Med. 2024;35(3):139

Original Article

Analysis of risk factors and the effect of specific treatments on the clinical outcome of patients hospitalized for COVID-19 at a university hospital in the Czech Republic

Černá Pařízková R., Astapenko D., Balík M., Blažek M., Dostál P., Dušek L., Fajfr M., Jarkovský J., Jurišínová I., Svobodová E., Szanyi J., Šmahel P., Černý V.

Anest. intenziv. Med. 2024;35(3):142-154 | DOI: 10.36290/aim.2024.034

Objective: The study aimed to evaluate the clinical outcome of patients hospitalized for COVID-19 in two university hospitals in 2021-2022, define risk factors, and evaluate the effect of specific treatment procedures. Design: A multicentric retrospective study. Setting: Intensive care units. Material and methods: The study included all adult patients hospitalized for COVID-19. The demographic data, comorbidities, degree of vaccination, ventilatory support, and pharmacotherapy were recorded. The study aimed to determine the impacts of selected risk factors, pharmacotherapy, and vaccination against SARS-CoV-2 on the clinical outcome. Results: A total...

Review Article

Spinal morphine up­‑to­‑date

Buršík D., Romanová T., Vodička V., Jor O., Máca J.

Anest. intenziv. Med. 2024;35(3):155-161 | DOI: 10.36290/aim.2024.030

Over many decades, spinal (intrathecal) opioid administration has become a proven method of analgesia for the perioperative period. However, in clinical practice, it is confronted with concerns about potential complications, the need for increased postoperative monitoring, and the unavailability of a relevant commercial product on the Czech market. Pathophysiological interpretation of adverse effects and their potential prevention is evolving as research continues. The implementation of spinal opioids in clinical practice is likewise changing. When used appropriately, it is a safe method to improve the postoperative course of the full spectrum of surgical...

Perioperative management in patients treated with gliflozins

Šitina M., Šrámek V.

Anest. intenziv. Med. 2024;35(3):162-167 | DOI: 10.36290/aim.2024.021

Patients treated with gliflozins, mostly with type 2 diabetes mellitus, may develop ketoacidosis with normal to moderately eleva­ted glycemia (euglycemic ketoacidosis) in the perioperative period. Therefore, gliflozins should be discontinued 3-4 days before elective surgery and only restarted when oral intake is reliably restored and the condition is clinically stable. In the case of minor surgery without the need for fasting, omitting gliflozins only the day before surgery and on the day of surgery may be considered. If gliflozins have not been discontinued, acid-base balance and, optimally, ketone bodies should be checked regularly until reliable...

Perioperative care of patients with chronic thromboembolic pulmonary hypertension undergoing pulmonary endarterectomy - twenty years of experience at an expert Centre in the Czech Republic

Kunstýř J., Lindner J., Jansa P., Michálek P.

Anest. intenziv. Med. 2024;35(3):168-175 | DOI: 10.36290/aim.2024.027

This year marks the 20th anniversary of the launch of the chronic thromboembolic pulmonary hypertension (CTEPH) surgical treatment programme, which involves three departments of the Cardiac Centre of the General University Hospital in Prague. Diagnosis and decision-making on the type of treatment, including indication for surgical treatment, is carried out at the Centre. Other non-surgical treatments and long-term dispensary care are also available to patients. Over 500 patients with CTEPH have been operated on during the program's lifetime. Our Centre also concentrates on patients with other types of severe pulmonary hypertension who are indicated...

The importance of perfusion and preservation solutions in perioperative medicine

Navrátil P., Břízová P., Astapenko D.

Anest. intenziv. Med. 2024;35(3):176-181 | DOI: 10.36290/aim.2024.029

Perfusion and preservation solutions are indispensable in the field of cardiothoracic surgery and transplantation. These solutions, developed to protect and maintain organs during surgical interventions, are crucial for preserving their viability and improving surgical outcomes. In the context of cardioplegia, they provide heart protection during cardiothoracic surgeries, enabling controlled cardiac arrest while minimizing myocardial metabolic activity. In transplantation, they maintain organ functionality during storage and transport. Research focuses on developing new solutions and techniques to further improve the organ protection and efficiency...

Case Report

A case of whole­‑body rigidity in a patient after orthopedic surgery

Tlapáková K., Černá Pařízková R., Astapenko D.

Anest. intenziv. Med. 2024;35(3):182-184 | DOI: 10.36290/aim.2024.031

In our case report, we present a case of swiftly manifesting malignant neuroleptic syndrome in a patient after orthopedic surgery who was treated for a new onset of delirium with a combination of antipsychotic drugs. Thanks to early diagnosis and treatment the patient didn't suffer any organ dysfunction and could have been discharged from our intensive care unit in two days back to the standard unit. The goal of this case report is to highlight this rare yet still life-threatening condition to our colleagues to help them take care of patients with such diagnoses in the future.

Short Communication

Choosing the optimal vascular access in perioperative and intensive care

Astapenko D., Kletečka J., Řehák D., Nosková P.

Anest. intenziv. Med. 2024;35(3):185-187 | DOI: 10.36290/aim.2024.036

The forgotten pioneer of medicine Med. et Chir. Dr. Augustin Göttinger

Vetešník J.

Anest. intenziv. Med. 2024;35(3):188-189 | DOI: 10.36290/aim.2024.035

Reports from professional societies

Congress EMHG 2024, Brno

Klincová M., Štěpánková D., Schröderová I., Tomášková V., Štourač P.

Anest. intenziv. Med. 2024;35(3):190-191 | DOI: 10.36290/aim.2024.037

CSARIM 2024 awards

redakce

Anest. intenziv. Med. 2024;35(3):192-198

Congress abstracts

The XXX national CSARIM congress abstracts

redakce

Anest. intenziv. Med. 2024;35(3):199-208


Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.